These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26116744)

  • 21. Treatment of pachydermoperiostosis pachydermia with botulinum toxin type A.
    Ghosn S; Uthman I; Dahdah M; Kibbi AG; Rubeiz N
    J Am Acad Dermatol; 2010 Dec; 63(6):1036-41. PubMed ID: 20933299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing clinical efficacy of botox and dysport in a small group of patients.
    Manstein CH; Beidas OE
    Plast Reconstr Surg; 2011 Jul; 128(1):26e-27e. PubMed ID: 21701303
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody-induced failure of botulinum toxin a therapy in cosmetic indications.
    Dressler D; Wohlfahrt K; Meyer-Rogge E; Wiest L; Bigalke H
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2182-7. PubMed ID: 21134050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines.
    Brandt F; O'Connell C; Cazzaniga A; Waugh JM
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2111-8. PubMed ID: 21134043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of two botulinum toxin type A preparations for treating crow's feet: a split-face, double-blind, proof-of-concept study.
    Prager W; Wissmüller E; Kollhorst B; Williams S; Zschocke I
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2155-60. PubMed ID: 21134046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, randomized, placebo-controlled health-outcomes survey of the effect of botulinum toxin type a injections on quality of life and self-esteem.
    Dayan SH; Arkins JP; Patel AB; Gal TJ
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2088-97. PubMed ID: 21070456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of botulinum toxin A on facial wrinkle lines in Koreans.
    Lew H; Yun YS; Lee SY; Kim SJ
    Ophthalmologica; 2002; 216(1):50-4. PubMed ID: 11901289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on botulinum toxin.
    Flynn TC
    Semin Cutan Med Surg; 2007 Dec; 26(4):196-202. PubMed ID: 18395667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin type a for facial rejuvenation: treatment evolution and patient satisfaction.
    Sepehr A; Chauhan N; Alexander AJ; Adamson PA
    Aesthetic Plast Surg; 2010 Oct; 34(5):583-6. PubMed ID: 20383497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glabellar gala.
    Weinberg JM; DeLeo VA
    Cutis; 2002 Jul; 70(1):15. PubMed ID: 12184666
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety and efficacy of administering abobotulinumtoxinA through a single injection point when treating lateral periocular rhytides.
    Kiripolsky MG; Goldman MP
    J Cosmet Dermatol; 2011 Sep; 10(3):232-4. PubMed ID: 21896136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IncobotulinumtoxinA in esthetics.
    Kerscher M; Yutskovskaya Y; Flynn TC
    J Drugs Dermatol; 2013 Jun; 12(6):e111-20. PubMed ID: 23839200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of botulinum toxin type A on the healing of facial skin biopsies - series of cases.
    Padulla GA; Bagatin E; Hirata SH; Yarak S
    An Bras Dermatol; 2018; 93(4):610-611. PubMed ID: 30066781
    [No Abstract]   [Full Text] [Related]  

  • 34. A cause for frowning: the BOTOX party.
    Benedetto AV
    Skinmed; 2002; 1(2):129-30. PubMed ID: 14673338
    [No Abstract]   [Full Text] [Related]  

  • 35. Neurotoxins: Evidence for Prevention.
    Humphrey S
    J Drugs Dermatol; 2017 Jun; 16(6):s87-s90. PubMed ID: 29028859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes.
    Carruthers J; Carruthers A; Monheit GD; Davis PG
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2135-45. PubMed ID: 21070457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
    Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin type A for facial aesthetic enhancement: role in facial shaping.
    Fagien S
    Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):6S-18S; discussion 19S-20S. PubMed ID: 14504481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Conservative treatment of facial wrinkles in the hands of the plastic surgeon].
    Brüner S; Deb R; Germann G
    Chirurg; 2003 Sep; 74(9):815-20. PubMed ID: 14504793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical resistance to three types of botulinum toxin type A in aesthetic medicine.
    Stephan F; Habre M; Tomb R
    J Cosmet Dermatol; 2014 Dec; 13(4):346-8. PubMed ID: 25399628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.